Can a simple blood test predict dangerous immunotherapy side effects?
NCT ID NCT03409016
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 15 times
Summary
This study is trying to find blood markers that could warn doctors ahead of time if a cancer patient will have serious side effects from immunotherapy drugs. About 69 adults with advanced solid tumors are being followed to see if certain inflammatory or autoimmune markers in their blood are different between those who get side effects and those who don't. The goal is to make immunotherapy safer by identifying at-risk patients early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado Denver
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.